Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)
NCT04589208Phase 2Active, not recruiting
- Sponsor
- New York State Psychiatric Institute
- Start
- Jan 2021
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine, sponsored by New York State Psychiatric Institute. Started Jan 2021; status: active, not recruiting.
02
Drugs
ketamine
Beyond the preview
Go deeper on NCT04589208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04589208.